Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) is scheduled to announce Q1 earnings results on Thursday, May 1st, before market open. The consensus EPS Estimate is -$3.79 and the consensus Revenue ...

Analysts expect Madrigal Pharmaceuticals to report an earnings per share (EPS) of $-3.83. The market awaits Madrigal Pharmaceuticals's announcement, with hopes high for news of surpassing estimates ...